Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
4.5The European Association of Urology (EAU) Pocket Guidelines App 2018 is the No. 1 resource for practicing urologists. Based on the most-read clinical guidelines in urology, the app provides you with access to comprehensive information on the management, investigation, diagnosis and follow-up of a wide-range of urological conditions on your mobile device. The development of clinical guidelines is one of the core activities of the EAU. The 2018 guidelines cover the majority of the urological field. Over 350 clinicians are involved in the production of the EAU Guidelines, which are updated based on the latest systematic reviews of the available clinical evidence. The EAU Pocket Guidelines App 2018 provides a quick and easy way in which to access the information provided in the 2018 Guidelines. The EAU Pocket Guidelines App 2018 covers the following topics: - Non-muscle invasive bladder cancer - Urothelial carcinomas of the upper urinary tract - Muscle-invasive and metastatic bladder cancer - Prostate cancer - Renal cell carcinoma - Testicular cancer - Penile cancer - Non-neurogenic male LUTS, including benign prostatic obstruction (BPO) - Urinary Incontinence - Neuro-urology - Male sexual dysfunction: erectile dysfunction and premature ejaculation - Priapism - Penile curvature - Male infertility - Male hypogonadism - Urological infections - Urolithiasis - Paediatric urology - Urological trauma - Chronic pelvic pain - Renal transplantation - Thromboprophylaxis in urological surgery In addition to providing on-the-go access to the information contained in the 2018 Pocket Guidelines, the app also includes 5 time-saving interactive tools to assist urologists in the treatment of their patients. These are: 1. An EORTC risk calculator for non-muscle-invasive bladder cancer; 2. An assessment algorithm of LUTS in men aged 40 years or older; 3. A tool for the evaluation of blunt renal trauma in adults; 4. A G8 geriatric screening tool for health status for Prostate cancer and Muscle-invasive bladder cancer; 5. A diagnostic and therapeutic algorithm for calcium oxalate stones.
